Literature DB >> 27474376

Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.

Eric P Moll van Charante1, Edo Richard2, Lisa S Eurelings3, Jan-Willem van Dalen3, Suzanne A Ligthart1, Emma F van Bussel1, Marieke P Hoevenaar-Blom3, Marinus Vermeulen3, Willem A van Gool4.   

Abstract

BACKGROUND: Cardiovascular risk factors are associated with an increased risk of dementia. We assessed whether a multidomain intervention targeting these factors can prevent dementia in a population of community-dwelling older people.
METHODS: In this open-label, cluster-randomised controlled trial, we recruited individuals aged 70-78 years through participating general practices in the Netherlands. General practices within each health-care centre were randomly assigned (1:1), via a computer-generated randomisation sequence, to either a 6-year nurse-led, multidomain cardiovascular intervention or control (usual care). The primary outcomes were cumulative incidence of dementia and disability score (Academic Medical Center Linear Disability Score [ALDS]) at 6 years of follow-up. The main secondary outcomes were incident cardiovascular disease and mortality. Outcome assessors were masked to group assignment. Analyses included all participants with available outcome data. This trial is registered with ISRCTN, number ISRCTN29711771.
FINDINGS: Between June 7, 2006, and March 12, 2009, 116 general practices (3526 participants) within 26 health-care centres were recruited and randomly assigned: 63 (1890 participants) were assigned to the intervention group and 53 (1636 participants) to the control group. Primary outcome data were obtained for 3454 (98%) participants; median follow-up was 6·7 years (21 341 person-years). Dementia developed in 121 (7%) of 1853 participants in the intervention group and in 112 (7%) of 1601 participants in the control group (hazard ratio [HR] 0·92, 95% CI 0·71-1·19; p=0·54). Mean ALDS scores measured during follow-up did not differ between groups (85·7 [SD 6·8] in the intervention group and 85·7 [7·1] in the control group; adjusted mean difference -0·02, 95% CI -0·38 to 0·42; p=0·93). 309 (16%) of 1885 participants died in the intervention group, compared with 269 (16%) of 1634 participants in the control group (HR 0·98, 95% CI 0·80-1·18; p=0·81). Incident cardiovascular disease did not differ between groups (273 [19%] of 1469 participants in the intervention group and 228 [17%] of 1307 participants in the control group; HR 1·06, 95% CI 0·86-1·31; p=0·57).
INTERPRETATION: A nurse-led, multidomain intervention did not result in a reduced incidence of all-cause dementia in an unselected population of older people. This absence of effect might have been caused by modest baseline cardiovascular risks and high standards of usual care. Future studies should assess the efficacy of such interventions in selected populations. FUNDING: Dutch Ministry of Health, Welfare and Sport; Dutch Innovation Fund of Collaborative Health Insurances; and Netherlands Organisation for Health Research and Development.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27474376     DOI: 10.1016/S0140-6736(16)30950-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  160 in total

Review 1.  Broadening the scope of epidemiologic dementia research.

Authors:  Sirwan K L Darweesh; Frank J Wolters; M Arfan Ikram; Daniel Bos; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2018-06-27       Impact factor: 8.082

2.  Primary prevention of dementia: from modifiable risk factors to a public brain health agenda?

Authors:  Felix S Hussenoeder; Steffi G Riedel-Heller
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-09-25       Impact factor: 4.328

Review 3.  [Prevention of cognitive decline and dementia by treatment of risk factors].

Authors:  Claus Escher; Frank Jessen
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

4.  Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health.

Authors:  Mary Ganguli; Emiliano Albanese; Sudha Seshadri; David A Bennett; Constantine Lyketsos; Walter A Kukull; Ingmar Skoog; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

5.  Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.

Authors:  Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 6.  Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive Decline.

Authors:  Chen Zhao; James M Noble; Karen Marder; Jacob S Hartman; Yian Gu; Nikolaos Scarmeas
Journal:  Curr Nutr Rep       Date:  2018-12

7.  Predictive Effect of Malnutrition on Long-Term Clinical Outcomes among Older Men: A Prospectively Observational Cohort Study.

Authors:  Y-H Hsu; M-Y Chou; C-S Chu; M-C Liao; Y-C Wang; Y-T Lin; L-K Chen; C-K Liang
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 8.  Roles of vascular risk factors in the pathogenesis of dementia.

Authors:  Shuko Takeda; Hiromi Rakugi; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2019-11-14       Impact factor: 3.872

9.  Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study.

Authors:  M Tabue-Teguo; P Barreto de Souza; C Cantet; S Andrieu; N Simo; B Fougère; J F Dartigues; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

10.  Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.

Authors:  Isabelle Bos; Stephanie J B Vos; Suzanne E Schindler; Jason Hassenstab; Chengjie Xiong; Elizabeth Grant; Frans Verhey; John C Morris; Pieter Jelle Visser; Anne M Fagan
Journal:  Alzheimers Dement       Date:  2019-08-01       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.